Skip to main content
OpenTrials
Completed

NCT Number: NCT03291717

Bridging Community Gaps Photovoice

The purpose of this study is to test a peer-led intervention intended to promote the community living and participation of individuals with psychiatric disabilities entitled "Bridging Community Gaps Photovoice" (BCGP). The intervention targets increasing community involvement of individuals with psychiatric disabilities through reduction in self-stigma and perceived stigma, enhancing opportunities for community participation, and support to achieve community participation goals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mental Health Center of Denver, Denver, Colorado, United States

Loading trial locations.

About this study

The BCGP intervention is 6 months long and the investigators expect that participants will experience lower self and perceived stigma, increased community participation and sense of belonging, and improved psychosocial functioning and personal growth after the intervention. The intervention is comprised of a 12-week class that meets once a week for two hours, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The purpose of the individual support is to reinforce the class activities and to ensure the participants meets their community participation goal. The proposed study is a randomized trial which will be conducted at Boston University Center for Psychiatric Rehabilitation (BUCPR) in Massachusetts, the Mental Health Center of Denver (MHCD) in Colorado, and the Greater Bridgeport Mental Health Center (GBMHC) in Connecticut.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • are 18 or older.
  • are recipients of services at research sites due to having a DSM-V diagnosis of mental illness, including dual diagnosis (dual diagnosis refers to co-occurring mental illness and alcohol/ substance use disorder).
  • are interested in enhancing their community participation.
  • are not currently receiving individual peer support services.
  • are able to read and write in English.

Exclusion criteria

1)Inability to give full and knowing consent.

Treatment and study plan

Bridging Community Gaps Photovoice (BCGP)

Behavioral

Participants assigned to this group will be part of the 6-month long BCGP intervention, which involves a 12- week class that meets weekly, followed by three booster sessions - one per month in the three months following the class, and up to 24 sessions of individual support as needed throughout the 6 months provided on a weekly basis either in person or by phone. The BCGP classes follow a manualized curriculum with sessions that combine didactic information, Photovoice exercises, and group discussions to empower participants in pursuing community participation goals, all refined with input from individuals with a lived experience.

Primary outcomes

  1. UCLA Loneliness Scale

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    is a 20-item 4-point Likert-type scale, widely used measure of loneliness and social isolation. Cronbach's alpha coefficients ranging from .89 to .94.

  2. Multi-Dimensional Assessment of Community Participation

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    Consists of a set of objective and subjective measures of community belonging, inclusion and participation.

Secondary outcomes

  1. Internalized Stigma of Mental Illness Scale

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    29-item, 4-point scale from (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing including alienation, stereotype endorsement, social withdrawal, stigma resistance.

  2. The Stigma Scale

    Time frame: Change from Baseline to 3 months, 3 months to 6 months, 6 months to 9 months, 9 months to 12 months

    28 item, 5 point scale (strongly disagree to strongly agree) measuring experienced and anticipated stigma.

  3. Approaches to Coping with Anti-Stigma

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    27-item instrument with a 4 point scale (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, educating, challenging, and distancing.

  4. Personal Growth and Recovery Scale

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    25-item, 4 point scale (strongly disagree to strongly agree) of items measuring psychosocial functioning and recovery.

  5. Community Goal Achievement Scale

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    adapted from Goal Attainment Scale, provides a structured approach to determining goal achievement regardless of the type or uniqueness of goal .

  6. Behavior and Symptom Identification Scale (BASIS - R)

    Time frame: Change from Baseline to 3 months to 6 months to 9 months to 12 months

    A 24-item scale that measures: mood disturbances, anxiety, interpersonal and role functioning, daily living skills, psychotic symptoms, impulsivity and substance use

Sponsors and collaborators

Lead sponsor

Boston University Charles River Campus

Other

Collaborators

  • Connecticut State, Department of Mental Health and Addiction Services
  • Mental Health Center of Denver
  • Riverside Community Care

Registry information

Official study title

Randomized Trial of a Peer-led Intervention to Promote Community Living and Participation - The Bridging Community Gaps Photovoice

Acronym: BCGP

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Sep 25, 2017
Registry last updated
Sep 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.